You are here: Industry Insights > clinical trials

News List

Envigo Launches PATHWAY contractpharma
March 13, 2019
Envigo has launched PATHWAY, an integrated solution designed to optimize non-clinical safety assessment programs to enable first-in-human clinical trials.
Structural barriers biggest reason for low participation in clinical trials europeanpharmaceuticalreview
February 21, 2019
A study has shown how structural barriers are one of the main reasons why clinical trials often do not meet their enrolment targets…
Boehringer Ingelheim (Canada) Ltd. and IBM Canada announce first of its kind collaboration to integrate blockchain technology into clinical trials worldpharmanews
February 13, 2019
Boehringer Ingelheim (Canada) Ltd. and IBM Canada announced at the Healthcare Information and Management Systems Society (HIMSS) conference in Orlando, Florida, their plans to explore the use of blockchain technology in clinical trials.
Correcting minority underrepresentation in MS clinical trials europeanpharmaceuticalreview
January 03, 2019
Minority unerrepresentation in clinical trials for drugs to treat MS has led to doctors being unable to make informed decisions when prescribing…
U.K. sets out digital, data-driven plan to accelerate R&D fiercebiotech
January 02, 2019
The U.K. government has set out how it plans to use data and digital technologies to attract clinical trials. Near-term plans include the creation of a system for assessing study feasibility and an app to connect patients to studies.....
Breast cancer clinical trials: top drugs under investigation pharmaceutical-technology
December 25, 2018
Breast cancer is the most commonly diagnosed cancer in women, the second most commonly diagnosed cancer overall, and is the fifth largest cause of cancer mortality worldwide.
GSK begins clinical trials of pancreatic cancer combination pharmaphorum
December 03, 2018
GlaxoSmithKline plans to carry out clinical trials on its pancreatic drug hopeful, GSK547, following promising results when treating mice and laboratory-grown tumour cells.
TRACON & I-Mab Partner for Immuno-Oncology contractpharma
November 30, 2018
TRACON Pharmaceuticals and I-Mab Biopharmajointly announced the establishment of a series of strategic collaborative partnerships for developing multiple immuno-oncology programs, including I-Mab’s proprietary CD73 antibody TJD5
FDA Approves First Treatment for Rare Autoimmune Disorder contractpharma
November 30, 2018
Catalyst Pharmaceuticals, Inc. received approval from the FDA for Firdapse (amifampridine) tablets for the treatment of Lambert-Eaton myasthenic syndrome (LEMS) in adults. LEMS is a rare autoimmune disorder that affects the connection between nerves
MPs voice concern over clinical trials transparency pharmatimes
November 05, 2018
MPs have expressed concern that nearly half of clinical trials in the UK fail to publish their results, “presenting risks to human health and increasing...

Previous page 1 2 3 4 5 6 7 8 9 10 ... 13 14 Next page